Pulmonary abnormalities in congestive heart failure: reversal by the inhaled anticholinergic agent ipratropium bromide

dc.contributor.author	Yesildag, O
dc.contributor.author	Unsal, M
dc.contributor.author	Yazici, M
dc.contributor.author	Bahadi, H
dc.contributor.author	Yilmaz, O
dc.date.accessioned	2020-06-21T15:49:49Z
dc.date.available	2020-06-21T15:49:49Z
dc.date.issued	2000
dc.identifier.issn	0195-668X
dc.identifier.uri	https://hdl.handle.net/20.500.12712/22307
dc.description	WOS: 000089136602560	en_US
dc.description.abstract	…	en_US
dc.language.iso	eng	en_US
dc.publisher	W B Saunders Co Ltd	en_US
dc.rights	info:eu-repo/semantics/closedAccess	en_US
dc.title	Pulmonary abnormalities in congestive heart failure: reversal by the inhaled anticholinergic agent ipratropium bromide	en_US
dc.type	conferenceObject	en_US
dc.contributor.department	OMÜ	en_US
dc.identifier.volume	21	en_US
dc.identifier.startpage	660	en_US
dc.identifier.endpage	660	en_US
dc.relation.journal	European Heart Journal	en_US
dc.relation.publicationcategory	Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı	en_US

Files in this item

Files	Size	Format	View
There are no files associated with this item.